EPAS1 and nonpapillary renal cell carcinoma: This finding was further validated at the protein level by examination of DCLK1 isoform 1 and isoform 2 (Fig. 2D), suggesting that HIF2α is the key regulator of DCLK1-L activation in ccRCC.